NCT01736163View on ClinicalTrials.gov

A Retrospective Observational Study Comparing Two Different Treatment Options in Thyroid Cancer Patients With T4 Tumours

CompletedOBSERVATIONAL

Enrollment

144

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions

Thyroid Cancer

Interventions

DRUG

Thyrogen

0.9 mg IM, administrated for 2 consecutive days

DRUG

131I

28 mCi or ≥ 1.036 GBq.

OTHER

Thyroid Hormone Withdrawal

Stop taking hormone therapy

Trial Locations (9)

Unknown

Hanover University School of Medicine, Hanover

Klinikum Großhadern, München

Policlinico S.Orsola-Malpighi, Bologna

Instituto Oncologico Veneto, Padua

Istituti Fisioterapici Ospitalieri (IFO), Rome

Portuguese Institute of Oncology, Coimbra

Hospital Universitario Reina Sofía, Córdoba

Hospital Universitario Virgen de las Nieves, Granada

Hospital Universitario Dr Peset, Valencia

All Listed Sponsors

lead

Genzyme, a Sanofi Company

INDUSTRY

NCT01736163 - A Retrospective Observational Study Comparing Two Different Treatment Options in Thyroid Cancer Patients With T4 Tumours | Biotech Hunter | Biotech Hunter